The hippocampus and septal area as primary target sites for corticosterone.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D002540:Cerebral Cortex / Q000032:analysis; D002855:Chromatography, Thin Layer; D003345:Corticosterone / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D004347:Drug Interactions; D006624:Hippocampus / Q000032:analysis / Q000378:metabolism*; D006846:Hydrocarbons, Halogenated; D007031:Hypothalamus / Q000032:analysis; D008297:Male; D010902:Pituitary Gland / Q000032:analysis; D011149:Pons / Q000032:analysis; D011506:Proteins / Q000032:analysis; D051381:Rats; D011955:Receptors, Drug; D012688:Septum Pellucidum / Q000032:analysis / Q000378:metabolism*; D012997:Solvents; D014316:Tritium
D006846:Hydrocarbons, Halogenated; D011506:Proteins; D011955:Receptors, Drug; D012997:Solvents; D014316:Tritium; D003345:Corticosterone